Prefrontal cortical network connections: Key site of vulnerability in stress and schizophrenia

International Journal of Developmental Neuroscience

Volumn 29, Issue 3, 2011, Pages 215-223

  Arnsten, Amy F T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CAMP; Catecholamines; DISC1; Physiology; Prefrontal cortex; RGS4; Working memory

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE C;

ARTICLE; BRAIN DYSFUNCTION; CHRONIC STRESS; COGNITIVE DEFECT; DELUSION; DENDRITIC SPINE; DOPAMINE METABOLISM; GABAERGIC SYSTEM; HALLUCINATION; HUMAN; MOLECULAR PATHOLOGY; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NERVE CELL NETWORK; NEUROPATHOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RECEPTOR UPREGULATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STRESS; SYMPTOM; THOUGHT DISORDER; WORKING MEMORY;

DENDRITIC SPINES; DOPAMINE; HUMANS; NERVE NET; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 79953311277     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.02.006     Document Type: Article

References (112)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.R., Keilp J., Kochan L., Van Heertum R., Gorman J.M., Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 2002, 22:3708-3719.
2. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 1999, 156:1580-1589.
3. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 1986, 9:357-381.
4. Arnsten A.F.T. Stress signaling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 2009, 32:267-287.
5. Arnsten A.F.T., Goldman-Rakic P.S. Stress impairs prefrontal cortex cognitive function in monkeys: role of dopamine. Soc. Neurosci. Abstr. 1990, 16:164.
6. Arnsten A.F.T., Vijayraghavan S., Wang M., Gamo N.J., Paspalas C.D. Dopamine's influence on prefrontal cortical cognition: actions and circuits in behaving primates. Dopamine Handbook 2009, 230-249. Oxford University Press, Oxford, UK. A. Bjorklund, S. Dunnett, L. Iversen, S. Iversen (Eds.).
7. Arnsten A.F.T., Paspalas C.D., Gamo N.J.Y.Y., Wang M. Dynamic network connectivity: a new form of neuroplasticity. Trends Cogn. Sci. 2010, 14:365-375.
8. Barch D.M. The cognitive neuroscience of schizophrenia. Annu. Rev. Clin. Psychol. 2005, 1:321-353.
9. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., Quinlan E.M., Nakazawa K. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 2010, 13:76-83.
10. Birnbaum S.B., Yuan P., Wang M., Vijayraghavan S., Bloom A., Davis D., Gobeske K., Sweatt D., Manji H.K., Arnsten A.F.T. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004, 306:882-884.
11. Boess F.G., De Vry J., Erb C., Flessner T., Hendrix M., Luithle J., Methfessel C., Riedl B., Schnizler K., van der Staay F.J., van Kampen M., Wiese W.B., Koenig G. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents. J. Pharmacol. Exp. Ther. 2007, 321:716-725.
12. Breier A., Wolkowitz O., Pickar D. Stress and schizophrenia: advances in neuropsychiatry and psychopharmacology. Schizophrenia Research 1991, Raven Press, Ltd., New York. C. Tamminga, S. Schult (Eds.).
13. Buccafusco J.J., Terry A.V.J. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochem. Pharmacol. 2009, 78:852-862.
14. Buckholtz J.W., Meyer-Lindenberg A., Honea R.A., Straub R.E., Pezawas L., Egan M.F., Vakkalanka R., Kolachana B., Verchinski B.A., Sust S., Mattay V.S., Weinberger D.R., Callicott J.H. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J. Neurosci. 2007, 27:1584-1593.
15. Buschman T.J., Miller E.K. Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices. Science 2007, 315:1860-1862.
16. Calabrese B., Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005, 48:77-90.
17. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., Kaprio J., Mazziotta J., Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 2005, 62:1205-1213.
18. Chan W.K., Wong P.T., Sheu F.S. Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory. Neuropharmacology 2007, 2007:1641-1649.
19. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., Deshpande S.N., Ferrell R.E., Middleton F.A., Devlin B., Levitt P., Lewis D.A., Nimgaonkar V.L. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 2002, 11:1373-1380.
20. Corlett P.R., Murray G.K., Honey G.D., Aitken M.R., Shanks D.R., Robbins T.W., Bullmore E.T., Dickinson A., Fletcher P.C. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain 2007, 130(Pt. 9):2387-2400.
21. Dawson M.E., Schell A.M., Rissling A., Ventura J., Subotnik K.L., Nuechterlein K.H. Psychophysiological prodromal signs of schizophrenic relapse: a pilot study. Schizophr. Res. 2010, (Epub ahead of print).
22. Duffy A.M., Zhou P., Milner T.A., Pickel V.M. Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse. Neuroscience 2009, 161:1091-1103.
23. Eack S.M., George M.M., Prasad K.M., Keshavan M.S. Neuroanatomical substrates of foresight in schizophrenia. Schizophr. Res. 2008, 103:62-70.
24. Erdely H.A., Tamminga C.A., Roberts R.C., Vogel M.W. Regional alterations in RGS4 protein in schizophrenia. Synapse 2006, 59:472-479.
25. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., Steel G., Nestadt G., Liang K.Y., Huganir R.L., Valle D., Pulver A.E. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005, 77:918-936.
26. Fleming Y.M., Frame M.C., Houslay M.D. PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration. J. Cell Sci. 2004, 117:2377-2388.
27. Ford J.M., Mathalon D.H., Whitfield S., Faustman W.O., Roth W.T. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol. Psychiatry 2002, 51:485-492.
28. Funahashi S., Bruce C.J., Goldman-Rakic P.S. Dorsolateral prefrontal lesions and oculomotor delayed-response performance: evidence for mnemonic " scotomas" J. Neurosci. 1993, 13:1479-1497.
29. Fuster J.M. Executive frontal functions. Exp. Brain Res. 2000, 133:66-70.
30. Fuster J.M. The Prefrontal Cortex 2008, Academic Press. fourth ed.
31. Gamo, N.J., Kata, A., Boven, L., Bryan, C., Lo, T., Anighoro, K., Bermudez. L., Peng, K., Annor. A., Taylor, S., Patel, K., Duque, A., Simen, A.A., Arnsten, A.F.T., 2010. Knock-down of disrupted in schizophrenia 1 (DISC1) in the rat prefrontal cortex lowers the threshold for stress-induced cognitive dysfunction. Soc. Neurosci., Abstracts 507.7.
32. Gao W.J., Krimer L.S., Goldman-Rakic P.S. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:295-300.
33. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
34. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14:477-485.
35. Gonzalez-Burgos G., Hashimoto T., Lewis D.A. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr. Psychiatry Rep. 2010, 12:335-344.
36. González-Burgos G., Barrionuevo G., Lewis D.A. Horizontal synaptic connections in monkey prefrontal cortex: an in vitro electrophysiological study. Cereb. Cortex 2000, 10:82-92.
37. Gorelova N.A., Seamans J.K., Yang C.R. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J. Neurophysiol. 2002, 88:150-166.
38. Gourley S.L., Kedves A.T., Olausson P., Taylor J.R. A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 2009, 34:707-716.
39. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci. 2000, 20:1208-1215.
40. Guo N., Hwang D.R., Lo E.S., Huang Y.Y., Laruelle M., Abi-Dargham A. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia. Neuropsychopharmacology 2003, 28:1703-1711.
41. Hains A.B., Vu M.A., Maciejewski P.K., van Dyck C.H., Gottron M., Arnsten A.F. Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17957-17962.
42. Hajós M., Rogers B.N. Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia. Curr. Pharm. Des. 2010, 16:538-554.
43. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., Xie Z., Baraban J.M., Houslay M.D., Tomoda T., Brandon N.J., Kamiya A., Yan Z., Penzes P., Sawa A. Disrupted-in-schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 2010, 13:327-332.
44. Hill J.J., Hashimoto T., Lewis D.A. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 2006, 11:557-566.
45. Ide M., Lewis D.A. Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol. Psychiatry 2010, 68:25-32.
46. Ishizuka K., Paek M., Kamiya A., Sawa A. A review of disrupted-in-schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol. Psychiatry 2006, 59:1189-1197.
47. Javitt D.C. Glutamatergic theories of schizophrenia. Isr. J. Psychiatry Relat. Sci. 2010, 47:4-16.
48. Jurado M.A., Junqué C., Vendrell P., Treserras P., Grafman J. Overestimation and unreliability in " feeling-of-doing" judgements about temporal ordering performance: impaired self-awareness following frontal lobe damage. J. Clin. Exp. Neuropsychol. 1998, 20:353-364.
49. Keedy S.K., Ebens C.L., Keshavan M.S., Sweeney J.A. Functional magnetic resonance imaging studies of eye movements in first episode schizophrenia: smooth pursuit, visually guided saccades and the oculomotor delayed response task. Psychiatry Res. 2006, 146:199-211.
50. Keefe R.S., Perkins D.O., Gu H., Zipursky R.B., Christensen B.K., Lieberman J.A. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr. Res. 2006, 88:26-35.
51. Kegeles L.S., Abi-Dargham A., Frankle W.G., Gil R., Cooper T.B., Slifstein M., Hwang D.R., Huang Y., Haber S.N., Laruelle M. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch. Gen. Psychiatry 2010, 67:231-239.
52. Kinney J.W., Davis C.N., Tabarean I., Conti B., Bartfai T., Behrens M.M. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J. Neurosci. 2006, 26:1604-1615.
53. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., Roberts R.C. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol. 2006, 497:436-450.
54. Knight R.T., Grabowecky M.F., Scabini D. Role of human prefrontal cortex in attention control. Adv. Neurol. 1995, 66:21-34.
55. Kristiansen L.V., Patel S.A., Haroutunian V.H., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64:495-502.
56. Kritzer M.F., Goldman-Rakic P.S. Intrinsic circuit organization of the major layers and sublayers of the dorsolateral prefrontal cortex in the rhesus monkey. J. Comp. Neurol. 1995, 359:131-143.
57. Kroner S., Krimer L.S., Lewis D.A., Barrionuevo G. Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb. Cortex 2007, 17:1020-1032.
58. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 2003, 169:215-233.
59. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9235-9240.
60. Lee D., Rushworth M.F., Walton M.E., Watanabe M., Sakagami M. Functional specialization of the primate frontal cortex during decision making. J. Neurosci. 2007, 27:8170-8173.
61. Leonard S., Freedman R. Genetics of chromosome 15q13-q14 in schizophrenia. Biol. Psychiatry 2006, 60:115-122.
62. Levin E.D., McClernon F.J., Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 2006, 184:523-539.
63. Lewis D.A., Gonzalez-Burgos G.R. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 2006, 12:1016-1022.
64. Liston C., McEwen B.S., Casey B.J. Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:912-917.
65. Liu J., Pearlson G., Windemuth A., Ruano G., Perrone-Bizzozero N.I., Calhoun V. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum. Brain Mapp. 2009, 30:241-255.
66. Martin L.F., Freedman R. Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int. Rev. Neurobiol. 2007, 78:225-246.
67. Millar J.K., Wilson-Annan J.C., Anderson S.L., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9:1415-1423.
68. Millar J.K., Mackie S., Clapcote S.J., Murdoch H., Pickard B.S., Christie S., Muir W.J., Blackwood D.H., Roder J.C., Houslay M.D., Porteous D.J. Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness. J. Physiol. 2007, 584:401-405.
69. Millar J.K., Pickard B.S., Mackie S., James R.S., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
70. Miller P.L., Lawrie S.M., Hodges A., Clafferty R., Cosway R., Johnstone E.C. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. 2001, 36:338-342.
71. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 2001, 6:293-301.
72. Modirrousta M., Fellows L.K. Dorsal medial prefrontal cortex plays a necessary role in rapid error prediction in humans. J. Neurosci. 2008, 28:14000-14005.
73. Morris D.W., Rodgers A., McGhee K.A., Schwaiger S., Scully P., Quinn J., Meagher D., Waddington J.L., Gill M., Corvin A.P. Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. 2004, 125B:50-53.
74. Murdoch H., Mackie S., Collins D.M., Hill E.V., Bolger G.B., Klussmann E., Porteous D.J., Millar J.K., Houslay M.D. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 2007, 27:9513-9524.
75. Murmu M.S., Salomon S., Biala Y., Weinstock M., Braun K., Bock J. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur. J. Neurosci. 2006, 24:1477-1487.
76. Murphy B.L., Arnsten A.F.T., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1325-1329.
77. Nuechterlein K.H., Dawson M.E., Gitlin M., Ventura J., Goldstein M.J., Snyder K.S., Yee C.M., Mintz J. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr. Bull. 1992, 18:387-425.
78. Paspalas C.D., Selemon L.D., Arnsten A.F. Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb. Cortex 2009, 19:2145-2155.
79. Perlstein W.M., Carter C.S., Noll D.C., Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry 2001, 158:1105-1113.
80. Prasad K.M., Chowdari K.V., Nimgaonkar V.L., Talkowski M.E., Lewis D.A., Keshavan M.S. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol. Psychiatry 2005, 10:213-219.
81. Radley J.J., Rocher A.B., Rodriguez A., Ehlenberger D.B., Dammann M., McEwen B.S., Morrison J.H., Wearne S.L., Hof P.R. Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J. Comp. Neurol. 2008, 507:1141-1150.
82. Rao S.G., Williams G.V., Goldman-Rakic P.S. Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. J. Neurophysiol. 1999, 81:1903-1916.
83. Rao S.G., Williams G.V., Goldman-Rakic P.S. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 2000, 20:485-494.
84. Robbins T.W. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:917-932.
85. Rosenberg D.R., Lewis D.A. Postnatal maturation of the dopaminergic innervation of monkey prefrontal cortices: a tyrosine hydroxylase immunohistochemical analysis. J. Comp. Neurol. 1995, 358:383-400.
86. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., Coyle J.T. Neurobiology of schizophrenia. Neuron 2006, 52:139-153.
87. Seeman P., Niznik H.B., Guan H.-C. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride. Arch. Gen. Psychiatry 1989, 47:1170-1172.
88. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 1998, 392:402-412.
89. Serrels B., Sandilands E., Serrels A., Baillie G.S., Houslay M.D., Brunton V.G., Canel M., Machesky L.M., Anderson K.I., Frame M.C. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity. Curr. Biol. 2010, 20:1086-1092.
90. Severance E.G., Yolken R.H. Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia. Genes Brain Behav. 2008, 7:37-45.
91. Sfakianos M.K., Eisman A., Gourley S.L., Bradley W.D., Scheetz A.J., Settleman J., Taylor J.R., Greer C.A., Williamson A., Koleske A.J. Inhibition of Rho via Arg and p190RhoGAP in the postnatal mouse hippocampus regulates dendritic spine maturation, synapse and dendrite stability, and behavior. J. Neurosci. 2007, 27:10982-10992.
92. Simons J.S., Henson R.N., Gilbert S.J., Fletcher P.C. Separable forms of reality monitoring supported by the anterior prefrontal cortex. J. Cogn. Neurosci. 2008, 20:447-457.
93. Smiley J.F., Levey A.I., Ciliax B.J., Goldman-Rakic P.S. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:5720-5724.
94. Steiner H., Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 1998, 123:60-76.
95. Subramaniam K., Kounios J., Parrish T.B., Jung-Beeman M. A brain mechanism for facilitation of insight by positive affect. J. Cogn. Neurosci. 2008, (Epub ahead of print).
96. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., van Erp T.G., Thompson P.M., Toga A.W., Cannon T.D., Pantelis C. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 2008, (Epub ahead of print).
97. Szeszko P.R., Hodgkinson C.A., Robinson D.G., Derosse P., Bilder R.M., Lencz T., Burdick K.E., Napolitano B., Betensky J.D., Kane J.M., Goldman D., Malhotra A.K. DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol. Psychol. 2008, 79:103-110.
98. Thompson-Schill S.L., Jonides J., Marshuetz C., Smith E.E., D'Esposito M., Kan I.P., Knight R.T., Swick D. Effects of frontal lobe damage on interference effects in working memory. Cogn. Affect. Behav. Neurosci. 2002, 2:109-120.
99. Thomsen M.S., Hansen H.H., Timmerman D.B., Mikkelsen J.D. Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr. Pharm. Des. 2010, 16:323-343.
100. Torreano P.J., Waterman-Storer C.M., Cohan C.S. The effects of collapsing factors on F-actin content and microtubule distribution of Helisoma growth cone. Cell Motil. Cytoskeleton 2005, 60:166-179.
101. Vidal C.N., Rapoport J.L., Hayashi K.M., Geaga J.A., Sui Y., McLemore L.E., Alaghband Y., Giedd J.N., Gochman P., Blumenthal J.D., Gogtay N., Nicolson R., Toga A.W., Thompson P.M. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Arch. Gen. Psychiatry 2006, 63:25-34.
102. Vijayraghavan S., Wang M., Birnbaum S.G., Bruce C.J., Williams G.V., Arnsten A.F.T. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 2007, 10:376-384.
103. Volk D.W., Eggan S.M., Lewis D.A. Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am. J. Psychiatry 2010, 167:1489-1498.
104. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 2000, 57:237-245.
105. Wang H.X., Gao W.J. Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 2009, 34:2028-2040.
106. Wang M., Vijayraghavan S., Goldman-Rakic P.S. Selective D2 receptor actions on the functional circuitry of working memory. Science 2004, 303:853-856.
107. Wang M., Ramos B., Paspalas C., Shu Y., Simen A., Duque A., Vijayraghavan S., Brennan A., Dudley A.G., Nou E., Mazer J.A., McCormick D.A., Arnsten A.F.T. Alpha2A-adrenoceptor stimulation strengthens working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 2007, 129:397-410.
108. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 1986, 43:114-124.
109. Wilkins A.J., Shallice T., McCarthy R. Frontal lesions and sustained attention. Neuropsychologia 1987, 25:359-365.
110. Wong D.F., Wagner H.N.J., Tune L.E., Dannals R.F., Pearlson G.D., Links J.M., Tamminga C.A., Broussolle E.P., Ravert H.T., Wilson A.A., Toung J.K., Malat J., Williams J.A., O'Tuama L.A., Snyder S.H., Kuhar M.J., Gjedde A. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986, 234:1558-1563.
111. Yang, Y., Gamo, N.J., Arnsten, A.F.T., Wang, M., 2010. Alpha7 nicotinic receptor influences on prefrontal cortex network physiology. Soc. Neurosci., Abstracts 507.8.
112. Yokoyama Y., Ito T., Hanson V., Schwartz G.K., Aderem A.A., Holland J.F., Tamaya T., Ohnuma T. PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells. Int. J. Cancer 1998, 75:774-779.